The 2018 Conference on Retroviruses and Opportunistic Infections (CROI) was held from March...
- CROI 2018: Early stage R&D sets guideposts for future CMV therapies
- Pfizer’s rituximab biosimilar edges closer to approval
- Novo Nordisk diabetes drug demonstrates weight loss in obese adults
- Abivax HIV treatment shows positive results
- Auris’ tinnitus treatment fails late-stage study for the second time
CROI 2018: Early stage R&D sets guideposts for future CMV therapies
The 2018 Conference on Retroviruses and Opportunistic Infections (CROI) was held from March 4th to the 7th in Boston, Massachusetts, US.
AbbVie forms new partnership to better study multiple myeloma
AbbVie has collaborated with the International Myeloma Foundation (IMF) to perform a retrospective chart review study to gain insights into multiple myeloma (MM) and better manage the disease.
Pfizer’s rituximab biosimilar edges closer to approval
Pfizer’s rituximab biosimilar candidate, PF-05280586, edged closer towards approval on January 24, 2018, when the company announced positive top-line results in a Phase III trial in follicular lymphoma (FL).
Improved Patient Delivery Service From New Drug Delivery Device
Pressure in healthcare management continues to grow. New treatments must be safe, efficient and more cost-effective than anything that has come before them.
Novo Nordisk diabetes drug demonstrates weight loss in obese adults
Positive trial results suggests that semaglutide, which is already approved for the treatment of type 2 diabetes, may also be effective in promoting weight loss in obese adults without diabetes.
Streamlined and Cost-Effective Wet Formulation Development
MVIC's FD concept offers a streamlined, cost-effective, and high-quality performed inhalation formulation development package for customers that either lack resources to perform a development programme or require cutting-edge input for problem solving.
JP and MCH to Attend 11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
JP and MCH have announced they will be showcasing products at the 11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology in Granada, Spain.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.